- Magg, Thomas;
- Shcherbina, Anna;
- Arslan, Duran;
- Desai, Mukesh M;
- Wall, Sarah;
- Mitsialis, Vanessa;
- Conca, Raffaele;
- Unal, Ekrem;
- Karacabey, Neslihan;
- Mukhina, Anna;
- Rodina, Yulia;
- Taur, Prasad D;
- Illig, David;
- Marquardt, Benjamin;
- Hollizeck, Sebastian;
- Jeske, Tim;
- Gothe, Florian;
- Schober, Tilmann;
- Rohlfs, Meino;
- Koletzko, Sibylle;
- Lurz, Eberhard;
- Muise, Aleixo M;
- Snapper, Scott B;
- Hauck, Fabian;
- Klein, Christoph;
- Kotlarz, Daniel
Background
Children with very early onset inflammatory bowel diseases (VEO-IBD) often have a refractory and severe disease course. A significant number of described VEO-IBD-causing monogenic disorders can be attributed to defects in immune-related genes. The diagnosis of the underlying primary immunodeficiency (PID) often has critical implications for the treatment of patients with IBD-like phenotypes.Methods
To identify the molecular etiology in 5 patients from 3 unrelated kindred with IBD-like symptoms, we conducted whole exome sequencing. Immune workup confirmed an underlying PID.Results
Whole exome sequencing revealed 3 novel CARMIL2 loss-of-function mutations in our patients. Immunophenotyping of peripheral blood mononuclear cells showed reduction of regulatory and effector memory T cells and impaired B cell class switching. The T cell proliferation and activation assays confirmed defective responses to CD28 costimulation, consistent with CARMIL2 deficiency.Conclusion
Our study highlights that human CARMIL2 deficiency can manifest with IBD-like symptoms. This example illustrates that early diagnosis of underlying PID is crucial for the treatment and prognosis of children with VEO-IBD.